Severe sepsis and septic shock.

Sepsis, a complex physiological and metabolic response to infection, is a common reason for admission to an intensive care unit. This review examines the basis, diagnosis, and current treatment of this disorder.

[1]  C. Forbes,et al.  Prevention of Deep Vein Thrombosis in Medical Patients by Low-Dose Heparin , 1981, Scottish medical journal.

[2]  M. Weinstein,et al.  The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. , 1983, Reviews of infectious diseases.

[3]  F. Cerra.  The systemic septic response: multiple systems organ failure. , 1985, Critical care clinics.

[4]  P. Andersen,et al.  Genetic and environmental influences on premature death in adult adoptees. , 1988, The New England journal of medicine.

[5]  B. Wiggs,et al.  Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. , 1990, Annals of internal medicine.

[6]  D. Mathieu,et al.  Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: A prospective, controlled clinical study , 1991, Critical care medicine.

[7]  G. Majno.  The ancient riddle of sigma eta psi iota sigma (sepsis). , 1991, The Journal of infectious diseases.

[8]  C. Sprung,et al.  The ACCP-SCCM consensus conference on sepsis and organ failure. , 1992, Chest.

[9]  R. Prielipp,et al.  Prolonged weakness after infusion of atracurium in two intensive care unit patients. , 1994, Anesthesia and analgesia.

[10]  D. Pittet,et al.  The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.

[11]  Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. , 1996 .

[12]  R. Bone,et al.  Sepsis: a new hypothesis for pathogenesis of the disease process. , 1997, Chest.

[13]  K. Asadullah,et al.  Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. , 1997, Nature medicine.

[14]  J. Vincent,et al.  Has the mortality of septic shock changed with time. , 1998, Critical care medicine.

[15]  Leibovici,et al.  The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection , 1998, Journal of internal medicine.

[16]  M. Giuliani,et al.  Causes of neuromuscular weakness in the intensive care unit: A study of ninety‐two patients , 1998, Muscle & nerve.

[17]  K. Gubler,et al.  Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial , 1998 .

[18]  Vanek Vw.  Meta-analysis of effectiveness of intermittent pneumatic compression devices with a comparison of thigh-high to knee-high sleeves. , 1998 .

[19]  A. Laplanche,et al.  Earlier Positivity of Central-Venous- versus Peripheral-Blood Cultures Is Highly Predictive of Catheter-Related Sepsis , 1998, Journal of Clinical Microbiology.

[20]  P. Bollaert,et al.  Reversal of late septic shock with supraphysiologic doses of hydrocortisone. , 1998, Critical care medicine.

[21]  C. Carvalho,et al.  Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. , 1998, The New England journal of medicine.

[22]  D. J. Bryg,et al.  Immunonutrition in the critically ill: a systematic review of clinical outcome. , 1999, Critical care medicine.

[23]  A. Turpie,et al.  A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. , 1999, The New England journal of medicine.

[24]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[25]  M. Haller,et al.  Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. , 1999, Critical care medicine.

[26]  R. Bellomo,et al.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial , 2000, The Lancet.

[27]  G Sherman,et al.  The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.

[28]  E. Rackow,et al.  Effects of perfusion pressure on tissue perfusion in septic shock , 2000, Critical care medicine.

[29]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[30]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[31]  J. Helterbrand,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis , 2003 .

[32]  M. Griffin,et al.  Continuous versus intermittent renal replacement therapy: a meta-analysis , 2001, Intensive Care Medicine.

[33]  Derek C. Angus,et al.  Epidemiology of sepsis: An update , 2001, Critical care medicine.

[34]  S. Opal,et al.  High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial , 2001 .

[35]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[36]  R. Hotchkiss,et al.  Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans1 , 2001, The Journal of Immunology.

[37]  Isabelle Durand-Zaleski,et al.  Paresis acquired in the intensive care unit: a prospective multicenter study. , 2002, JAMA.

[38]  Véronique Sébille,et al.  Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock , 2002 .

[39]  C. Guérin,et al.  Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: results from a multicenter prospective epidemiological survey , 2002, Intensive Care Medicine.

[40]  C. Coopersmith,et al.  Depletion of Dendritic Cells, But Not Macrophages, in Patients with Sepsis , 2002, The Journal of Immunology.

[41]  D. Annane,et al.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. , 2002, JAMA.

[42]  D. Feller-Kopman,et al.  Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[44]  D. Angus,et al.  Surviving Intensive Care: a report from the 2002 Brussels Roundtable , 2003, Intensive Care Medicine.

[45]  P. Bossuyt,et al.  Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial , 2003, The Lancet.

[46]  G. Bernard,et al.  Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated). , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  C. Sprung,et al.  Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. , 2003, JAMA.

[48]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[49]  Fiona Simpson,et al.  Parenteral vs. enteral nutrition in the critically ill patient: a meta-analysis of trials using the intention to treat principle , 2004, Intensive Care Medicine.

[50]  Leonard Leibovici,et al.  β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials , 2004, BMJ : British Medical Journal.

[51]  Derek C Angus,et al.  Severe sepsis epidemiology: sampling, selection, and society , 2004, Critical care.

[52]  P. Pronovost,et al.  Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. , 2004, Critical care medicine.

[53]  Robyn Norton,et al.  A comparison of albumin and saline for fluid resuscitation in the Intensive Care unit , 2005 .

[54]  J. Handelsman,et al.  Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. , 2004, The Lancet. Infectious diseases.

[55]  M. Bonten,et al.  Antimicrobial therapy for patients with severe sepsis and septic shock: An evidence-based review , 2004, Critical care medicine.

[56]  D. Heyland,et al.  Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature. , 2004, Nutrition.

[57]  L. Leibovici,et al.  Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. , 2004, BMJ.

[58]  Mitchell M. Levy,et al.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Critical care medicine.

[59]  D. Heyland,et al.  Combination enteral and parenteral nutrition in critically ill patients: harmful or beneficial? A systematic review of the evidence , 2004, Intensive Care Medicine.

[60]  Brian Hutton,et al.  Reliability of point-of-care testing for glucose measurement in critically ill adults* , 2005, Critical care medicine.

[61]  F. Sebat,et al.  A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients. , 2005, Chest.

[62]  Soumitra R. Eachempati,et al.  Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. , 2005, Surgical infections.

[63]  F. Gao,et al.  The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study , 2005, Critical care.

[64]  Victoria J. Fraser,et al.  Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality , 2005, Antimicrobial Agents and Chemotherapy.

[65]  V. Pettilä,et al.  Hemodynamic variables related to outcome in septic shock , 2005, Intensive Care Medicine.

[66]  K. Wood,et al.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.

[67]  Max Harry Weil,et al.  Fluid challenge revisited , 2006, Critical care medicine.

[68]  S. Magder.  Central venous pressure: A useful but not so simple measurement , 2006, Critical care medicine.

[69]  R. Dellinger,et al.  Current treatment of severe sepsis , 2006, Current infectious disease reports.

[70]  Martin H Kroll,et al.  The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. , 2006, Archives of pathology & laboratory medicine.

[71]  Guillermo Bugedo,et al.  Lung recruitment in patients with the acute respiratory distress syndrome. , 2006, The New England journal of medicine.

[72]  S. Opal,et al.  High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: Efficacy and safety* , 2006, Critical care medicine.

[73]  J. Chiche,et al.  Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial , 2006, The Lancet.

[74]  J. Parrillo,et al.  Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. , 2006, Chest.

[75]  Scott T. Micek,et al.  Before–after study of a standardized hospital order set for the management of septic shock* , 2006, Critical care medicine.

[76]  Rafael Fernández,et al.  A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome. , 2006, American journal of respiratory and critical care medicine.

[77]  Daniel Talmor,et al.  Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol* , 2006, Critical care medicine.

[78]  A. Shorr,et al.  Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: A metaanalysis. , 2007, Chest.

[79]  Nigel Mackman,et al.  Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein C , 2007, The Journal of experimental medicine.

[80]  J. Sunderram,et al.  Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003* , 2007, Critical care medicine.

[81]  S. Weber-Carstens,et al.  Impact of bolus application of low-dose hydrocortisone on glycemic control in septic shock patients , 2007, Intensive Care Medicine.

[82]  A. Delaney,et al.  Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: A systematic review and meta‐analysis * , 2007, Critical care medicine.

[83]  D. Annane,et al.  Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial , 2007, The Lancet.

[84]  Robert Steele,et al.  Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality* , 2007, Critical care medicine.

[85]  S. Jaber,et al.  Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. , 2008, JAMA.

[86]  J. G. van der Hoeven,et al.  Accuracy of bedside glucose measurement from three glucometers in critically ill patients* , 2008, Critical care medicine.

[87]  A. Limaye,et al.  Reactivation of Cytomegalovirus Infection in Critically Ill Immunocompetent Patients—Reply , 2008 .

[88]  M. Levy,et al.  Reducing mortality in severe sepsis: the Surviving Sepsis Campaign. , 2008, Clinics in chest medicine.

[89]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[90]  T. van der Poll,et al.  Host-pathogen interactions in sepsis. , 2008, The Lancet. Infectious diseases.

[91]  M. Levy,et al.  Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. , 2008, JAMA.

[92]  A. Boyer,et al.  Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management , 2009, Intensive Care Medicine.

[93]  N. Khardori.  Hydrocortisone Therapy for Patients with Septic Shock , 2008 .

[94]  M. Meade,et al.  Recruitment maneuvers for acute lung injury: a systematic review. , 2008, American journal of respiratory and critical care medicine.

[95]  P. Marik,et al.  Immunonutrition in critically ill patients: a systematic review and analysis of the literature , 2008, Intensive Care Medicine.

[96]  D. Annane,et al.  Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia , 2010, Intensive Care Medicine.

[97]  J. A. Kaan,et al.  Decontamination of the digestive tract and oropharynx in ICU patients. , 2009, The New England journal of medicine.

[98]  N. Adhikari,et al.  Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis , 2010, Intensive Care Medicine.

[99]  Anand Kumar,et al.  Sepsis and septic shock: a history. , 2009, Critical care clinics.

[100]  Jay Steingrub,et al.  International study of the prevalence and outcomes of infection in intensive care units , 2009 .

[101]  M. Dünser,et al.  Macroscopic Postmortem Findings in 235 Surgical Intensive Care Patients with Sepsis , 2009, Anesthesia and analgesia.

[102]  L. Pagano,et al.  Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection. , 2009, The Journal of infection.

[103]  L. Baddour,et al.  β-Lactam and Fluoroquinolone Combination Antibiotic Therapy for Bacteremia Caused by Gram-Negative Bacilli , 2009, Antimicrobial Agents and Chemotherapy.

[104]  A. Kumar,et al.  Cytomegalovirus Reactivation in Critically Ill Immunocompetent Patients , 2009 .

[105]  N. Webster,et al.  Immunomodulation in the critically ill , 2009, British Journal of Anaesthesia.

[106]  Jordi Rello,et al.  International study of the prevalence and outcomes of infection in intensive care units. , 2009, JAMA.

[107]  Richard Beale,et al.  The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis , 2010, Intensive Care Medicine.

[108]  C. Schorr.  Performance improvement in the management of sepsis. , 2009, Critical care clinics.

[109]  S. Pongprasobchai,et al.  Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: a meta-analysis. , 2009, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[110]  Stephen L. Jones,et al.  Validation of a screening tool for the early identification of sepsis. , 2009, The Journal of trauma.

[111]  Djillali Annane,et al.  Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. , 2009, JAMA.

[112]  T. Baumann,et al.  Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. , 2009, American journal of respiratory and critical care medicine.

[113]  R. Ariano,et al.  The use of antiviral agents for the management of severe influenza , 2010, Critical care medicine.

[114]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[115]  D. Mazzon,et al.  End-of-life decision-making and quality of ICU performance: an observational study in 84 Italian units , 2010, Intensive Care Medicine.

[116]  W. Ruf.  New players in the sepsis-protective activated protein C pathway. , 2010, The Journal of clinical investigation.

[117]  T. van der Poll,et al.  Inflammation and coagulation , 2010, Critical care medicine.

[118]  Matthias Briel,et al.  Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. , 2010, JAMA.

[119]  J. Grimshaw,et al.  A study of the perceived risks, benefits and barriers to the use of SDD in adult critical care units (The SuDDICU study) , 2010, Trials.

[120]  C. Natanson,et al.  Bundled care for septic shock: An analysis of clinical trials* , 2010, Critical care medicine.

[121]  G. Rubenfeld,et al.  Critical care and the global burden of critical illness in adults , 2010, The Lancet.

[122]  J. Bakker,et al.  Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. , 2010, American journal of respiratory and critical care medicine.

[123]  Leonard Leibovici,et al.  Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis , 2010, Antimicrobial Agents and Chemotherapy.

[124]  F. Bozza,et al.  Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients , 2010, Critical care.

[125]  W. Junger,et al.  Circulating Mitochondrial DAMPs Cause Inflammatory Responses to Injury , 2009, Nature.

[126]  D. White,et al.  A randomized trial of two methods to disclose prognosis to surrogate decision makers in intensive care units. , 2010, American journal of respiratory and critical care medicine.

[127]  Richard Beale,et al.  The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis* , 2010, Critical care medicine.

[128]  Pei-Chin Lin,et al.  The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: A meta-analysis , 2010, Critical care medicine.

[129]  Joshua A. Doherty,et al.  Empiric Combination Antibiotic Therapy Is Associated with Improved Outcome against Sepsis Due to Gram-Negative Bacteria: a Retrospective Analysis , 2010, Antimicrobial Agents and Chemotherapy.

[130]  D. Angus,et al.  Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. , 2010, JAMA.

[131]  G. Waterer,et al.  Genetic predisposition to respiratory infection and sepsis , 2011, Critical reviews in clinical laboratory sciences.

[132]  Arthur S Slutsky,et al.  Broken Barriers: A New Take on Sepsis Pathogenesis , 2011, Science Translational Medicine.

[133]  S. Zanotti-Cavazzoni.  Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis , 2011 .

[134]  Y. Dou,et al.  Epigenetic regulation of immune cell functions during post-septic immunosuppression , 2011, Epigenetics.

[135]  G. Van den Berghe,et al.  Early versus Late Parenteral Nutrition in Critically Ill Adults , 2011, The New England journal of medicine.

[136]  G. Guyatt,et al.  Dalteparin versus unfractionated heparin in critically ill patients. , 2011, The New England journal of medicine.

[137]  H. Galley.  Oxidative stress and mitochondrial dysfunction in sepsis. , 2011, British journal of anaesthesia.

[138]  A. Delaney,et al.  The role of albumin as a resuscitation fluid for patients with sepsis: A systematic review and meta-analysis* , 2011, Critical care medicine.

[139]  T. Shim,et al.  Low‐dose hydrocortisone treatment for patients with septic shock: A pilot study comparing 3 days with 7 days , 2011, Respirology.

[140]  L. Hanson,et al.  Randomized, controlled trials of interventions to improve communication in intensive care: a systematic review. , 2011, Chest.

[141]  K. Tyml.  Critical Role for Oxidative Stress, Platelets, and Coagulation in Capillary Blood Flow Impairment in Sepsis , 2011, Microcirculation.

[142]  A. Patterson,et al.  Genetic polymorphisms in sepsis. , 2011, Critical care nursing clinics of North America.

[143]  Derek C Angus,et al.  The search for effective therapy for sepsis: back to the drawing board? , 2011, JAMA.

[144]  Tak W. Mak,et al.  Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit , 2011, Science.

[145]  Michael B. Rothberg,et al.  Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007 , 2012, Critical care medicine.

[146]  R. D. Blasi,et al.  Immature platelet fraction in predicting sepsis in critically ill patients , 2013, Intensive Care Medicine.

[147]  Ulf Andersson,et al.  Reflex principles of immunological homeostasis. , 2012, Annual review of immunology.

[148]  Frédérique Jacobs,et al.  Antibiotic strategies in severe nosocomial sepsis: Why do we not de-escalate more often?* , 2012, Critical care medicine.

[149]  S. Nasraway,et al.  Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients , 2012, Critical care medicine.

[150]  S. Zanotti-Cavazzoni,et al.  Nationwide Trends of Severe Sepsis in the 21st Century (2000-2007) , 2012 .

[151]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 , 2013, Intensive Care Medicine.

[152]  H. Wong.  Clinical review: Sepsis and septic shock - the potential of gene arrays , 2012, Critical Care.

[153]  M. Büchler,et al.  Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. , 2012, JAMA.

[154]  Gordon H Guyatt,et al.  Executive Summary Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2012 .

[155]  K. Tracey,et al.  Alarmins: awaiting a clinical response. , 2012, The Journal of clinical investigation.

[156]  Andrew Rhodes,et al.  Drotrecogin alfa (activated) in adults with septic shock. , 2012, The New England journal of medicine.

[157]  R. Hotchkiss,et al.  Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure , 2012 .

[158]  J. Vincent,et al.  Dopamine versus norepinephrine in the treatment of septic shock: A meta-analysis* , 2012, Critical care medicine.

[159]  Understanding the potential role of statins in pneumonia and sepsis , 2012 .

[160]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[161]  B. Guidet,et al.  Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study , 2012, Critical Care.

[162]  I. Douglas,et al.  Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsis , 2012, The Pharmacogenomics Journal.

[163]  S. D. S. dos Santos,et al.  Sepsis in AIDS patients: clinical, etiological and inflammatory characteristics , 2013, Journal of the International AIDS Society.

[164]  R. Gamelli,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013, Proceedings of the National Academy of Sciences.

[165]  H. Masur,et al.  Critical care of persons infected with the human immunodeficiency virus. , 2013, Clinics in chest medicine.

[166]  T. Miyakawa,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013 .